{"count": 5, "results": [{"_id": "25963345", "pmid": 25963345, "pmcid": "PMC4830304", "title": "Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial", "journal": "Chin Med J (Engl)", "authors": ["Cai XL", "Chen YL", "Zhao JJ", "Shan ZY", "Qiu MC", "Li CJ", "Gu W", "Tian HM", "Yang HZ", "Xue YM", "Yang JK", "Hong TP", "Ji LN"], "date": "2015-05-20T00:00:00Z", "doi": "10.4103/0366-6999.156735", "meta_date_publication": "2015 May 20", "meta_volume": "128", "meta_issue": "10", "meta_pages": "1279-87", "score": 50077.355, "text_hl": "Comparable results concluded from this study in Chinese @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@ @SPECIES_9606 @@@patients@@@ also indicated that there may be no ethnicity difference in @<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@ treatment.", "citations": {"NLM": "Cai XL, Chen YL, Zhao JJ, Shan ZY, Qiu MC, Li CJ, Gu W, Tian HM, Yang HZ, Xue YM, Yang JK, Hong TP, Ji LN. Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial Chin Med J (Engl). 2015 May 20;128(10):1279-87. PMID: 25963345", "BibTeX": "@article{25963345, title={Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial}, author={Cai XL and Chen YL and Zhao JJ and Shan ZY and Qiu MC and Li CJ and Gu W and Tian HM and Yang HZ and Xue YM and Yang JK and Hong TP and Ji LN}, journal={Chin Med J (Engl)}, volume={128}, number={10}, pages={1279-87}}"}}, {"_id": "17563269", "pmid": 17563269, "title": "Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.", "journal": "Expert Opin Pharmacother", "authors": ["Smiley D", "Umpierrez G"], "date": "2007-06-01T00:00:00Z", "doi": "10.1517/14656566.8.9.1353", "meta_date_publication": "2007 Jun", "meta_volume": "8", "meta_issue": "9", "meta_pages": "1353-64", "score": 50074.39, "text_hl": "@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@Metformin@@@/@CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ combination pill (@<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@) for the treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 diabetes@@@.", "citations": {"NLM": "Smiley D, Umpierrez G. Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes. Expert Opin Pharmacother. 2007 Jun;8(9):1353-64. PMID: 17563269", "BibTeX": "@article{17563269, title={Metformin/rosiglitazone combination pill (Avandamet) for the treatment of patients with Type 2 diabetes.}, author={Smiley D and Umpierrez G}, journal={Expert Opin Pharmacother}, volume={8}, number={9}, pages={1353-64}}"}}, {"_id": "15529521", "pmid": 15529521, "title": "Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.", "journal": "Int J Clin Pract", "authors": ["Bailey CJ", "Day C"], "date": "2004-09-01T00:00:00Z", "doi": "10.1111/j.1742-1241.2004.00318.x", "meta_date_publication": "2004 Sep", "meta_volume": "58", "meta_issue": "9", "meta_pages": "867-76", "score": 50073.164, "text_hl": "@<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@: combined @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@-@CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@ treatment for @DISEASE_Insulin_Resistance @DISEASE_MESH:D007333 @@@insulin resistance@@@ in @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes@@@.", "citations": {"NLM": "Bailey CJ, Day C. Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes. Int J Clin Pract. 2004 Sep;58(9):867-76. PMID: 15529521", "BibTeX": "@article{15529521, title={Avandamet: combined metformin-rosiglitazone treatment for insulin resistance in type 2 diabetes.}, author={Bailey CJ and Day C}, journal={Int J Clin Pract}, volume={58}, number={9}, pages={867-76}}"}}, {"_id": "21682834", "pmid": 21682834, "title": "A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients.", "journal": "Diabetes Obes Metab", "authors": ["Borges JL", "Bilezikian JP", "Jones-Leone AR", "Acusta AP", "Ambery PD", "Nino AJ", "Grosse M", "Fitzpatrick LA", "Cobitz AR"], "date": "2011-11-01T00:00:00Z", "doi": "10.1111/j.1463-1326.2011.01461.x", "meta_date_publication": "2011 Nov", "meta_volume": "13", "meta_issue": "11", "meta_pages": "1036-46", "score": 50051.72, "text_hl": "A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of @<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@ (@CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@/@CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@) and @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@ on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@type 2 diabetes mellitus@@@ @SPECIES_9606 @@@patients@@@.", "citations": {"NLM": "Borges JL, Bilezikian JP, Jones-Leone AR, Acusta AP, Ambery PD, Nino AJ, Grosse M, Fitzpatrick LA, Cobitz AR. A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients. Diabetes Obes Metab. 2011 Nov;13(11):1036-46. PMID: 21682834", "BibTeX": "@article{21682834, title={A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients.}, author={Borges JL and Bilezikian JP and Jones-Leone AR and Acusta AP and Ambery PD and Nino AJ and Grosse M and Fitzpatrick LA and Cobitz AR}, journal={Diabetes Obes Metab}, volume={13}, number={11}, pages={1036-46}}"}}, {"_id": "20840734", "pmid": 20840734, "pmcid": "PMC2982694", "title": "A systems biology approach to identify effective cocktail drugs", "journal": "BMC Syst Biol", "authors": ["Wu Z", "Zhao XM", "Chen L"], "date": "2010-09-13T00:00:00Z", "doi": "10.1186/1752-0509-4-S2-S7", "meta_date_publication": "2010 Sep 13", "meta_volume": "4 Suppl 2", "meta_issue": "Suppl 2", "meta_pages": "S7", "score": 50050.9, "text_hl": "In the subnetwork affected by @<m>CHEMICAL_rosiglitazone_metformin_combination</m> @CHEMICAL_MESH:C471074 @@@Avandamet@@@ (combination drug), 16 @<m>DISEASE_Diabetes_Mellitus_Type_2</m> @DISEASE_MESH:D003924 @@@Type 2 Diabetes@@@ related genes are included, and are listed in Table 2. ", "citations": {"NLM": "Wu Z, Zhao XM, Chen L. A systems biology approach to identify effective cocktail drugs BMC Syst Biol. 2010 Sep 13;4 Suppl 2(Suppl 2):S7. PMID: 20840734", "BibTeX": "@article{20840734, title={A systems biology approach to identify effective cocktail drugs}, author={Wu Z and Zhao XM and Chen L}, journal={BMC Syst Biol}, volume={4 Suppl 2}, number={Suppl 2}, pages={S7}}"}}]}